NASDAQ · Analyst Forecast

Biofrontera Inc. (BFRI) Stock Forecast & Price Target

$0.59 NASDAQ: BFRI Market Cap $8.81M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Biofrontera Inc. (BFRI), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Biofrontera Inc., analysts forecast revenue rising from $40.75M in 2025 to $109.18M in 2030; the average estimate for 2030 earnings per share is $0.58; with published estimates ranging from $0.57 to $0.59; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$40.38M$40.75M$41.12M1
2026$45.98M$46.40M$46.82M1
2027$52.82M$53.30M$53.78M1
2028$65.84M$68.36M$70.88M2
2029$85.62M$86.39M$87.17M1
2030$108.20M$109.18M$110.17M1

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$1.41−$1.39−$1.371
2026−$0.18−$0.18−$0.181
2027$0.42$0.43$0.441
2028$0.11$0.19$0.272
2029$0.31$0.31$0.311
2030$0.57$0.58$0.591

Biofrontera Inc. (BFRI) forecast — frequently asked questions

What are analysts forecasting for Biofrontera Inc.'s earnings?

The average analyst estimate for Biofrontera Inc. (BFRI) earnings per share in 2030 is 0.58, with individual estimates between 0.57 and 0.59.

How much revenue is Biofrontera Inc. expected to make?

Analysts forecast Biofrontera Inc. (BFRI) revenue of $109.18M in 2030, based on 1 published estimates.

How many analysts cover BFRI?

2 analysts contribute estimates for Biofrontera Inc. (BFRI). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Pharmaceuticals stocks

RPRX forecastCORT forecastLQDA forecastPBH forecastQUIT forecastHITI forecastETRA stockTRXB stockAll Medical - Pharmaceuticals stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.